(Q65369987)
Statements
ENESTFreedom (English)
0 references
A Single-arm, Multicenter, Nilotinib Treatment-free Remission Study in Patients With BCR-ABL1 Positive Chronic Myelogenous Leukemia in Chronic Phase Who Have Achieved Durable Minimal Residual Disease (MRD) Status on First Line Nilotinib Treatment. (English)
0 references
4 March 2013
0 references
31 May 2016
0 references
221
0 references
18 year
0 references